Cargando…

Toripalimab-Induced Dermatomyositis in a Patient with Metastatic Melanoma

Toripalimab is a monoclonal antibody targeting programmed cell death protein 1 (PD-1). It has recently been approved as an immune checkpoint inhibitor in second-line therapies in patients with unresectable or metastatic melanoma; however, it may be associated with various immune-related adverse even...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Jingrong, Xue, Minmin, Gao, Mingyang, Yu, Pu, Han, Shixin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367952/ https://www.ncbi.nlm.nih.gov/pubmed/32445174 http://dx.doi.org/10.1007/s13555-020-00396-6

Ejemplares similares

Long-Term Survival of FOLFIRINOX +toripalimab in a Patient with Metastatic Pancreatic Ductal Adenocarcinoma: A Case Report
por: Jiang, Ting, et al.
Publicado: (2022)

Combination therapy (toripalimab and lenvatinib)-associated toxic epidermal necrolysis in a patient with metastatic liver cancer: A case report
por: Huang, Kai-Kai, et al.
Publicado: (2022)

Toripalimab plus axitinib in patients with metastatic mucosal melanoma: 3-year survival update and biomarker analysis
por: Li, Siming, et al.
Publicado: (2022)

Toripalimab in advanced biliary tract cancer
por: Li, Wei, et al.
Publicado: (2022)

Paclitaxel/toripalimab: Leucopenia and gastrointestinal reaction: case report
Publicado: (2021)

Paraneoplastic Dermatomyositis Associated with Metastatic Seminoma
por: Yoshie, Hidekazu, et al.
Publicado: (2016)

Efficacy and safety of toripalimab combined with doxorubicin as first-line treatment for metastatic soft tissue sarcomas: an observational study
por: Liu, Zhiyong, et al.
Publicado: (2021)

Dermatomyositis and Paclitaxel-Induced Cutaneous Drug Eruption Associated with Metastatic Breast Cancer
por: Kim, Youngji, et al.
Publicado: (2015)

Paraneoplastic dermatomyositis associated with metastatic leiomyosarcoma of unknown primary
por: Merry, Eve, et al.
Publicado: (2020)

Case Report: Good cardiac tolerance to Toripalimab in a CVD patient with oral melanoma
por: Pan, Wei, et al.
Publicado: (2022)

Severe cumulative skin toxicity during toripalimab combined with vemurafenib following toripalimab alone
por: Zhou, Hong, et al.
Publicado: (2023)

Axitinib in Combination With Toripalimab, a Humanized Immunoglobulin G(4) Monoclonal Antibody Against Programmed Cell Death-1, in Patients With Metastatic Mucosal Melanoma: An Open-Label Phase IB Trial
por: Sheng, Xinan, et al.
Publicado: (2019)

Anti–melanoma differentiation–associated gene 5 dermatomyositis complicated by myopericarditis
por: Milani-Nejad, Nima, et al.
Publicado: (2019)

An unusual anti–melanoma differentiation–associated protein 5 amyopathic dermatomyositis
por: Barailler, Héloïse, et al.
Publicado: (2019)

Blood purification in two patients with clinically amyopathic dermatomyositis associated with interstitial lung disease with anti-melanoma differentiation-associated gene-5 antibody (MDA-5)
por: Shi, Han-yu, et al.
Publicado: (2019)

Remarkable Response of Toripalimab Combined with Chemotherapy in Sarcomatoid Carcinoma of Palatine Tonsil: A Case Report
por: Huang, Jiahuan, et al.
Publicado: (2021)

Combination therapy with toripalimab and anlotinib in advanced esophageal squamous cell carcinoma: A case report
por: Chen, Si-Cong, et al.
Publicado: (2023)

Stuttering as a signal of encephalopathy associated with toripalimab in a pancreatic ductal adenocarcinoma patient: a case report
por: He, Jianping, et al.
Publicado: (2023)

Case Report: Toripalimab Combined With Anlotinib in a Patient With Metastatic Upper Tract Urothelial Carcinoma After Pembrolizumab Failure
por: Zan, Ning, et al.
Publicado: (2022)

SKAP2-BRAF fusion and response to an MEK inhibitor in a patient with metastatic melanoma resistant to immunotherapy
por: Chew, Sonya Minmin, et al.
Publicado: (2021)

Toripalimab combined with targeted therapy and chemotherapy achieves pathologic complete response in gastric carcinoma: A case report
por: Liu, Rui, et al.
Publicado: (2022)

Toripalimab combined with anlotinib for recurrent extensive‑stage small‑cell lung cancer: A case report
por: Wu, Ying, et al.
Publicado: (2023)

Rapidly progressive melanoma differentiation–associated protein 5–positive amyopathic dermatomyositis in an HIV-positive patient
por: Sharma, Ashutosh, et al.
Publicado: (2017)

Severe Thrombocytopenia in Patient with Dermatomyositis
por: TUDORANCEA, A.D., et al.
Publicado: (2018)

Slowly progressive interstitial lung disease preceding typical dermatomyositis symptoms in anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis
por: Isono, Taisuke, et al.
Publicado: (2021)

Dermatomyositis and HIV
por: Chand, Mamata, et al.
Publicado: (2016)

Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trial
por: Chen, Si-Yuan, et al.
Publicado: (2023)

Combination toripalimab and bevacizumab for an elderly urothelial carcinoma patient with brain metastasis who failed rapidly after radiotherapy: a case report and literature review
por: Qu, Fanjie, et al.
Publicado: (2022)

Dermatomyositis Developing in the first Trimester of Pregnancy
por: Park, In Whee, et al.
Publicado: (2003)

Toripalimab in an advanced non-small cell lung cancer patient with poor general condition after multiline treatment: a case report
por: He, Yuling, et al.
Publicado: (2021)

High PD‐L1 level of advanced hepatic lymphoepithelioma‐like carcinoma response favorably to lenvatinib plus toripalimab
por: Zhu, Yueting, et al.
Publicado: (2022)

Respiratory failure in a patient with dermatomyositis
por: Salimbene, Ivano, et al.
Publicado: (2013)

Paraneoplastic dermatomyositis in a patient with an oligodendroglioma
por: Kim, Esther, et al.
Publicado: (2019)

Distinct purpuric lesions in patients with dermatomyositis
por: Cho, Sung Kyung, et al.
Publicado: (2021)

6. Treatment resistant ulcerating dermatomyositis in metastatic melanoma treated with checkpoint inhibitor therapy
por: Parker, Lucy, et al.
Publicado: (2019)

Dermatomyositis and supraventricular tachycardia
por: Dhoble, Abhijeet, et al.
Publicado: (2008)

Juvenile Dermatomyositis in Pregnancy
por: Madu, Anthony Emeka, et al.
Publicado: (2013)

Durable Response and Good Tolerance to the Triple Combination of Toripalimab, Gemcitabine, and Nab-Paclitaxel in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma
por: Shui, Lin, et al.
Publicado: (2020)

Metastatic Melanoma of the Gallbladder in an Asymptomatic Patient
por: Khan, Asad, et al.
Publicado: (2017)

Clinically Amyopathic Dermatomyositis Caused by a Tattoo
por: Han, Bing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5melsk5i34foq18icrocuvkt2t